$29.50 Million in Sales Expected for CRH Medical Corporation (NASDAQ:CRHM) This Quarter
Wall Street analysts predict that CRH Medical Corporation (NASDAQ:CRHM) will post $29.50 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for CRH Medical’s earnings, with estimates ranging from $28.40 million to $30.60 million. CRH Medical posted sales of $27.33 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 7.9%. The business is scheduled to issue its next quarterly earnings results on Wednesday, August 7th.
On average, analysts expect that CRH Medical will report full-year sales of $129.10 million for the current year, with estimates ranging from $125.70 million to $132.30 million. For the next fiscal year, analysts expect that the business will report sales of $144.18 million, with estimates ranging from $132.40 million to $159.90 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover CRH Medical.
CRHM traded down $0.03 on Wednesday, hitting $2.71. The company had a trading volume of 167,300 shares, compared to its average volume of 67,906. CRH Medical has a 1 year low of $2.51 and a 1 year high of $4.50. The stock’s fifty day simple moving average is $2.85.
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Read More: Key terms to understand channel trading
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.